Drug shortage: Bupivacaine Hydrochloride Injection (BUPIVACAINE HYDROCHLORIDE, SENSORCAINE MPF, SENSORCAINE)
FDA lists 62 presentations as Current. Availability: Unavailable (4), Limited Availability (5), Available (48). Reason: Discontinuation of the manufacture of the drug; Demand increase for the drug. Companies: Hospira, Inc., a Pfizer Company, Aspiro Pharma Limited, Fresenius Kabi USA, LLC, Somerset Therapeutics, LLC, Kindos Pharmaceuticals Co. Ltd.….
- Published by source
- 2018-02-20
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Bupivacaine Hydrochloride Injection BUPIVACAINE HYDROCHLORIDE SENSORCAINE MPF SENSORCAINE MARCAINE SPINAL BUPIVACAINE SPINAL
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- Meitheal Pharmaceuticals is distributor/labeler
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2018-02-20
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #879 | new | 2026-10-22 | 30c858a05cdc…876000 | b97a44c4ddd8…78330f |
Chain head: #1094 edf3be25ec2e…478842